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Cool Heart
rotected From Infarction
linical Translation
f Breathing Chilled Liquids*
ilbur Y. W. Lew, MD, FACC
an Diego, California
yocardial hypothermia effectively reduces infarct size in
nimal models (1–3), particularly when initiated early,
apidly, and maintained for the duration of ischemia. It has
een difficult to translate this to the clinical setting because
he methods used to induce hypothermia (e.g., cardiac
urface cooling, arteriovenous extracorporeal heat exchang-
rs, and peritoneal cooling) are impractical for rapid imple-
entation with proven safety.
herapeutic Hypothermia
xternal cold packs and mattresses have been used to induce
ypothermia and improve neurologic outcomes in patients
esuscitated after cardiac arrest with ventricular fibrillation
n randomized, controlled trials (4,5). Core body tempera-
ures were lowered to 32°C to 34°C over 2 to 4 h and
aintained for 18 to 24 h without cardiac arrhythmias,
ncreasing cardiac enzymes, or major adverse events. Endo-
ascular cooling is another safe method for therapeutic
ypothermia in survivors of cardiac arrest (6). An endovas-
ular cooling catheter positioned in the inferior vena cava
ools local circulating blood to lower systemic temperatures
y 1.2°C/h.
See page 601
Endovascular cooling has been performed safely in pa-
ients with acute myocardial infarction undergoing percuta-
eous coronary interventions (PCI) (7,8). Core tempera-
ures were lowered to 34°C over 1 h, and hypothermia
aintained for 3 h without significant arrhythmias or
emodynamic compromise. Shivering, which causes sympa-
hetic activation that may exacerbate ischemia, was pre-
ented by external warming and pharmacologic agents
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.m
From the Cardiology Section 111A, Department of Medicine, Veterans Affairs San
iego Healthcare System, University of California, San Diego, San Diego, California.buspirone and meperidine). These studies were not pow-
red to determine if hypothermia reduced infarct size.
Although hypothermia induced over one or more hours is
europrotective after cardiac arrest (4,5) and is safe in acute
yocardial infarction (7,8), more rapid means for inducing
ypothermia may be required to observe the marked car-
ioprotective effects achieved in preclinical studies. In this
ssue of the Journal, Tissier et al. (9) induced hypothermia in
abbits using liquid ventilation with cooled perfluorocarbon
olutions to decrease left atrial temperature to 32°C within
min. Hypothermia reduced infarct size after ischemia-
eperfusion by 90%. Hypothermia during reperfusion was
neffective. This study is appealing for clinical translation
ecause of the rapidity of inducing hypothermia and the
linical safety of liquid ventilation (10,11).
iquid Ventilation
iquid ventilation utilizes the unique properties of perfluoro-
arbons (PFCs), which are stable and inert compounds with
ow surface tension that dissolve a large amount of respiratory
ases at atmospheric pressure and body temperature (10,11).
he high gas solubility of oxygen and carbon dioxide and low
urface tension permit effective gas exchange.
Liquid ventilation provides thermal control of the central
irculation and has been used for therapeutic hyperthermia
nd hypothermia, primarily in preclinical studies (11). The
ole use of PFCs for gas exchange (tidal or total liquid
entilation) provides more efficient thermal exchange and
tability than partial liquid ventilation, a hybrid technique
here the lungs are filled to functional residual capacity
ith PFCs with tidal volumes of gas superimposed.
Over the last decade, liquid ventilation has been used to
reat preterm neonatal and pediatric patients with acute lung
njury and adults with acute respiratory distress syndrome
ARDS) in phase II/III clinical trials (10,11). Partial liquid
entilation caused only mild, self-limited adverse events
ncluding hypoxia, respiratory acidosis, and bradycardia in a
andomized, controlled study with 90 ARDS patients (12).
n a randomized controlled trial with 311 adult patients
ith ARDS, partial liquid ventilation was safe but lacked
fficacy, with a failure to improve 28-day mortality or
entilator-free days (13). Adverse events including brady-
ardia, arrhythmia, and cardiac arrest, did not differ between
roups, but there was a higher incidence of pneumothorax,
ypoxia, and hypotension in patients treated with partial
iquid ventilation compared with conventional mechanical
entilation (13). Hypoxia and hypotension were related to
ransient interruptions of ventilatory support for additional
osing of PFCs. Thus, partial liquid ventilation with PFCs
s well tolerated and safe. There has been limited clinical
xperience with tidal liquid perfusion.
linical Applications
iquid ventilation can induce cardiac hypothermia within
inutes, which may effectively limit infarct size. The
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February 6, 2007:606–7 Editorial Commentfficiency of inducing hypothermia is comparable to extra-
orporeal blood heat exchangers and greater than with
ndovascular cooling. However, the requirement for intu-
ation and mechanical ventilation with chilled PFCs may
elay definitive therapy with primary PCI, and thus limit its
pplicability in acute coronary syndromes or ST-segment
levation myocardial infarction. It is difficult to obtain a
etailed medical history after a patient is intubated, which is
consequential limitation in this setting. However, in
linical scenarios where PCI is not immediately contem-
lated or available, liquid ventilation may be useful for
imiting infarct size.
In patients with atherosclerotic vascular disease undergo-
ng high-risk surgery, myocardial ischemia may occur as a
omplication that is not amenable to immediate coronary
evascularization. Postoperative myocardial infarction oc-
urs in 12% to 14% of men with stable coronary artery
isease after elective major vascular surgery, regardless of
hether or not they undergo coronary revascularization
efore surgery (14). Liquid ventilation can be applied readily
n patients who are already intubated and mechanically
entilated. Hypothermia may limit infarct size from myo-
ardial ischemia until the patient has stabilized and recov-
red from the stress and ischemic triggers associated with
urgery and anesthesia. Similarly, in patients with myocar-
ial ischemia due to profound blood loss or hypovolemia
ith hypotension, therapeutic hypothermia with liquid
entilation may limit infarct size during recovery after the
nderlying cause for acute myocardial ischemia is treated.
inally, liquid ventilation may be used to induce hypother-
ia within minutes in patients resuscitated after cardiac
rrest to limit infarct size. These cardioprotective effects
ay be additive to the neuroprotection observed when
ypothermia is induced over hours (4,5).
Potential problems with liquid ventilation include pneu-
othorax, transient hypotension, and hypoxia (13). The
FCs are radio-opaque and interfere with radiographic
maging, which can mask underlying pulmonary problems.
iquid ventilation is safe compared with conventional me-
hanical ventilation in ARDS (12,13), but in this setting
entilatory support is required to treat pulmonary abnor-
alities (e.g., pulmonary edema, inflammation, loss of
urfactant, decreased lung compliance, etc.) that cause a
igh mortality. In the normal lung, liquid ventilation may
orsen gas exchange by creating ventilation/perfusion mis-
atches and disturbing normal lung mechanics (10). Po-
ential complications can be minimized by using liquid
entilation to rapidly induce cardiac hypothermia during the
ritical early hours of myocardial ischemia, and then imple-
ent (slower) nonventilatory methods to maintain hypo-
hermia. The risks of brief ventilatory support with PFCs
ay be acceptable in view of the high risks associated withyocardial infarction and clear benefits derived from reduc-
ng infarct size.
In summary, liquid ventilation is a novel approach for
apidly inducing cardiac hypothermia with cardioprotective
ffects. Liquid ventilation with PFCs has been safely used in
umans in clinical trials. This method may provide an
pportunity to translate the benefits of cardiac hypothermia,
hich have been well documented in preclinical studies, to
he clinical setting to limit infarct size in patients with
yocardial ischemia.
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